Frontage Laboratories, Inc. ("Frontage"), a global Contract Research, Development and Manufacturing Organization (CRDMO), today announced the expansion of its early phase clinical research ...
Mohs microscopic surgery and image-guided superficial radiation therapy (IG-SRT) demonstrate high cure rates for non-melanoma ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.
Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results